Monocytosis Definition
Monocytosis is defined as an absolute monocyte count greater than 1.0 × 10⁹/L (>1000/μL) in peripheral blood. 1, 2
Diagnostic Threshold
The World Health Organization (WHO) 2008 classification establishes an absolute monocyte count >1.0 × 10⁹/L as the primary cutoff for defining monocytosis, which is the threshold used specifically in the diagnostic criteria for chronic myelomonocytic leukemia (CMML). 1
This threshold represents the standard used across hematologic classifications for myeloid neoplasms and distinguishes absolute monocytosis from relative monocytosis (where monocytes are elevated as a percentage but the absolute count remains <1.0 × 10⁹/L). 3
Clinical Context
Persistent monocytosis is defined as sustained elevation ≥3 months without evidence of infection, inflammation, or malignancy, which warrants hematology referral according to WHO-based guidelines. 1
In the context of CMML diagnosis specifically, the WHO requires persistent peripheral blood monocytosis (>1 × 10⁹/L) as the first mandatory criterion, along with absence of Philadelphia chromosome or BCR-ABL1 fusion gene, less than 20% blasts in peripheral blood and bone marrow, and evidence of dysplasia or clonal abnormality. 4, 1
Important Distinction
Absolute monocytosis must be distinguished from relative monocytosis, where monocytes may be elevated as a percentage of total white blood cells but the absolute count remains below 1.0 × 10⁹/L. 2, 3
Myelodysplastic syndromes (MDS) can present with monocytosis, but the absolute monocyte count typically remains <1 × 10⁹/L, which differentiates it from CMML. 5, 3